Table 2 Distribution of the clinical information and survival status in three cohorts.

From: Systematic integration of m6A regulators and autophagy-related genes in combination with long non-coding RNAs predicts survival in glioblastoma multiforme

Clinical features

Subgroup

Total cohort

Training cohort

Test cohort

P value

Age

 ≤ 50

23(19.49%)

13(22.81%)

10(16.39%)

0.5181

 > 50

95(80.51%)

44(77.19%)

51(83.61%)

 

Gender

Female

46(38.98%)

21(36.84%)

25(40.98%)

0.7856

Male

72(61.02%)

36(63.16%)

36(59.02%)

 

IDH

Mutant

8(6.78%)

4(7.02%)

4(6.56%)

1

WT

110(93.22%)

53(92.98%)

57(93.44%)

 

MGMT

Methylated

50(42.37%)

26(45.61%)

24(39.34%)

0.6154

Unmethylated

68(57.63%)

31(54.39%)

37(60.66%)

 

Survival status

Alive

27(22.88%)

11(18.03%)

16(28.07%)

0.2811

Dead

91(77.12%)

50(81.97%)

41(71.93%)

 
  1. IDH isocitrate dehydrogenase, WT wild type, MGMT O6 methylguanine DNA methyltransferase.
Back to article page